Company: RPTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103764
Chunk: 58

Company: Repare Therapeutics Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 58
---
 executive officer’s options that are subject to time-based vesting schedule that were scheduled to vest in the six months following the date of termination, and the executive officer’s vested options (other than options qualifying as incentive stock options) would remain exercisable for up to nine months following the date of such termination. |

If within 90 days before or within 12 months following a change in control, either of Mr. Segal, Dr. Koehler and Dr. Zinda is terminated by us (or a successor) involuntarily without “cause” and not due to death or “disability” or the executive officer resigns for “good reason,” then:

| • |     | With respect to Mr. Segal, he would have been entitled to (1) a lump sum cash severance equal to 1.5 times the sum of base salary and the higher of his target bonus for the year in which the termination occurs or the annual bonus received for the prior year; (2) continued participation in our group insurance plans and employee benefits for 18 months; (3) full accelerated vesting of his options that were subject to time-based vesting schedule, and Mr. Segal’s vested options would have remained exercisable for up to 12 months following such termination; and (4) a lump sum payment equal to his target bonus pro-rated for the year of termination. |

| • |     | Dr. Koehler would have been, and Dr. Zinda would be, entitled to (1) a lump-sum cash severance equal to the sum of base salary and the higher of the executive officer’s target bonus for the year in which the termination occurs or the annual bonus received for the prior year; (2) payment of COBRA premiums for up to 12 months; and (3) full accelerated vesting of the executive officer’s options that are subject to time-based vesting schedule, and the executive officer’s vested options (other than options qualifying as incentive stock options) would remain exercisable for up to nine months following such termination. |

41

The severance payments and benefits under the employment agreements are, in all events, conditioned on the applicable executive officer, among other things, giving notice following a cure period (as applicable), complying with post-resignation or post termination obligations under the applicable agreement, including any non-disparagementand confidentiality obligations contained therein, and signing a general release of claims against us. Further, in the event the executive officer’s employment terminates due to death or “